|
ZNF498 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79001258260314E-12 |
| Normal-vs-Stage2 |
5.32239999961881E-07 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
1.62991842245219E-12 |
| Stage1-vs-Stage2 |
1.980440E-02 |
| Stage1-vs-Stage3 |
2.063600E-01 |
| Stage1-vs-Stage4 |
1.472350E-02 |
| Stage2-vs-Stage3 |
9.981900E-03 |
| Stage2-vs-Stage4 |
1.099400E-03 |
| Stage3-vs-Stage4 |
2.930200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.94029999961631E-07 |
| Normal-vs-Asian |
3.74200004316094E-10 |
| Caucasian-vs-AfricanAmerican |
5.229200E-01 |
| Caucasian-vs-Asian |
1.218160E-01 |
| AfricanAmerican-vs-Asian |
6.505800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.742600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.13464793116691E-13 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.63491442606301E-12 |
| Normal-vs-Age(81-100Yrs) |
1.67694999999579E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.351400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.923400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.461200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.808200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.132400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.868200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.69140000011647E-07 |
| Classical-VS-Follicular |
7.634200E-01 |
| Classical-VS-Other |
3.114200E-01 |
| Classical-VS-Normal |
4.78495021383196E-12 |
| Tall-VS-Follicular |
1.65739999999914E-05 |
| Tall-VS-Other |
2.355200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.293800E-01 |
| Follicular-VS-Normal |
1.08939524068319E-11 |
| Other-VS-Normal |
1.969360E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
9.9120711638534E-13 |
| N0-vs-N1 |
1.182550E-01 |
|
|
